Details of the Drug

General Information of Drug (ID: DM39Y9O)

Drug Name

Allo-APZ2-EB

Indication

Disease Entry	ICD 11	Status	REF
Epidermolysis bullosa	EC3Z	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03529877) An Interventional, Multicenter, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-EB on Epidermolysis Bullosa (EB). U.S.National Institutes of Health.